Scientists have combined two potent immunotherapies -- an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy -- to target and eradicate solid tumors that are otherwise difficult to treat with CAR T therapy alone.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200902152138.htm
No comments:
Post a Comment